Axogen director granted 5,579 RSUs valued at $235K
THOMAS PAUL reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
THOMAS PAUL reported acquisition or exercise transactions in this Form 4 filing.
Axogen, Inc. director Paul Thomas reported receiving a grant of 5,579 restricted stock units as equity compensation for his Board service. Each unit represents one share of common stock and the award is valued at $235,000 as of the grant date. The restricted stock units vest on June 24, 2027, the one-year anniversary of the grant date, and Thomas’s directly held derivative position from this grant totals 5,579 units after the transaction.
Insider Trade Summary
Grant/Award: 5,579 shares
Grant/Award
1 txn
Insider
THOMAS PAUL
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 5,579 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 5,579 contracts (Direct)
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- F2. Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $235,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date.
Key Figures
RSUs granted: 5,579 units
Grant valuation: $235,000
Price per RSU: $0.0000
+3 more
6 metrics
RSUs granted
5,579 units
Restricted stock unit award for Board service
Grant valuation
$235,000
Equity grant value as of grant date
Price per RSU
$0.0000
Reported transaction price per unit
Shares underlying RSUs
5,579 shares
Each RSU equals one share of common stock
Holdings after grant
5,579 RSUs
Total derivative holdings from this award
Vesting date
June 24, 2027
One-year anniversary of grant date
Key Terms
Restricted Stock Units, equity grant, contingent right, vests, +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
equity grant financial
"Annual equity grant for service as Director on the Axogen, Inc. Board"
contingent right financial
"represents a contingent right to receive one share of Axogen, Inc. common"
vests financial
"and vests on June 24, 2027, the one-year anniversary of the grant date"
derivative financial
"transaction_type": "derivative", "security_title": "Restricted Stock Units""
A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Axogen (AXGN) director Paul Thomas report in this Form 4?
Paul Thomas reported receiving 5,579 restricted stock units as equity compensation for service on Axogen’s Board of Directors. The award is in the form of derivatives that each convert into one share of common stock upon settlement.
How large is Paul Thomas’s new Axogen (AXGN) RSU award?
The award covers 5,579 restricted stock units, each tied to one share of common stock. According to the disclosure, the equity grant is based on a total valuation of $235,000 as of the grant date for his director service.
When do Paul Thomas’s Axogen (AXGN) restricted stock units vest?
The restricted stock units vest on June 24, 2027, which is the one-year anniversary of the grant date. Vesting means the units become earned and eligible to settle into Axogen common shares at that time, subject to applicable conditions.
What does each Axogen (AXGN) restricted stock unit represent in this filing?
Each restricted stock unit represents a contingent right to receive one share of Axogen common stock. The units are a form of stock-based compensation and do not involve any cash exercise price according to the reported transaction details.
Is the Paul Thomas Axogen (AXGN) Form 4 a market buy or sell?
No, the Form 4 reflects a grant or award acquisition coded as “A,” not an open-market trade. It is compensation in the form of restricted stock units, with a reported transaction price of $0.0000 per unit and no shares sold in this filing.
How many Axogen (AXGN) RSUs does Paul Thomas hold from this grant after the transaction?
After this transaction, Paul Thomas holds 5,579 restricted stock units from this specific grant. The filing lists this total as his derivative holdings following the award, all reported as directly owned, with no remaining option or warrant positions shown.
AI-generated analysis. How Rhea-AI works. Not financial advice.
